scholarly journals Economic Burden of Depression and Associated Resource Use in Manitoba, Canada

2019 ◽  
Vol 65 (5) ◽  
pp. 338-346 ◽  
Author(s):  
Julie-Anne Tanner ◽  
Jennifer Hensel ◽  
Paige E. Davies ◽  
Lisa C. Brown ◽  
Bryan M. Dechairo ◽  
...  
Keyword(s):  
Health Care ◽  
Health Care Utilization ◽  
Prescription Drug ◽  
Social Services ◽  
Economic Burden ◽  
Suicide Mortality ◽  
Care Utilization ◽  
Physician Visits ◽  
Depressed Patients ◽  
Self Harm

Objectives To characterize the health-care utilization and economic burden associated with depression in Manitoba, Canada. Methods Patient-level data were retrieved from the Manitoba Centre for Health Policy administrative, clinical, and laboratory databases for the study period of January 1, 1996, through December 31, 2016. Patients were assigned to the depression cohort based on diagnoses recorded in hospitalizations and outpatient physician claims, as well as antidepressant prescription drug claims. A comparison cohort of nondepressed subjects, matched with replacement for age, gender, place of residence (urban vs. rural), and index date, was created. Demographics, comorbidities, intentional self-harm, mortality, health-care utilization, prescription drug utilization, and costs of health-care utilization and social services were compared between depressed patients and matched nondepressed patients, and incidence rate ratios and hazard ratios were reported. Results There were 190,065 patients in the depression cohort and 378,177 patients in the nondepression cohort. Comorbidities were 43% more prevalent among depressed patients. Intentional self-harm, all-cause mortality, and suicide mortality were higher among patients with depression than the nondepression cohort. Health-care utilization—including hospitalizations, physician visits, physician-provided psychotherapy, and prescription drugs—was higher in the depression than the nondepression cohort. Mean health-care utilization costs were 3.5 times higher among depressed patients than nondepressed patients ($10,064 and $2,832, respectively). Similarly, mean social services costs were 3 times higher ($1,522 and $510, respectively). Overall, depression adds a total average cost of $8,244 ( SD = $40,542) per person per year. Conclusions Depression contributes significantly to health burden and per patient costs in Manitoba, Canada. Extrapolation of the results to the entire Canadian health-care system projects an excess of $12 billion annually in health system spending.

Half-Managed Care

2015 ◽  
Vol 47 (3) ◽  
pp. 519-531
Author(s):  
Shou-Hsia Cheng ◽  
Chih-Ming Chang ◽  
Chi-Chen Chen ◽  
Chih-Yuan Shih ◽  
Shu-Ling Tsai
Keyword(s):  
Health Care ◽  
Health Care Utilization ◽  
Estimating Equation ◽  
Emergency Department Visits ◽  
Care Utilization ◽  
The Novel ◽  
Minimal Impact ◽  
Physician Visits ◽  
Comparison Groups ◽  
Patient Model

In 2011, a novel capitation program was launched in Taiwan under its universal health insurance plan. This study aimed to assess the short-term impact of the program. Two hospitals in the greater Taipei area, one participating in the “loyal patient” model (13,319 enrollees) and one in the “regional resident” model (13,768 enrollees), were analyzed. Two comparison groups were selected by propensity score matching. Generalized estimating equation models with differences-in-differences analysis were used to examine the net effects of the capitation program on health care utilization, expenses, and outcomes. Enrollees in the loyal patient model had fewer physician visits in the host hospital, but more physician visits outside that hospital during the program year than they had the year before. Compared with non-enrollees, the loyal patient model enrollees incurred fewer physician visits (β = −0.042, p < .001), fewer emergency department visits, (β = −0.140, p < .001), and similar total expenses and outcome. For the regional resident model, no differences were found in the number of physician visits, expenses, or outcomes between enrollees and non-enrollees. The novel capitation models in Taiwan had minimal impact on health care utilization after 1 year of implementation and the health care outcome was not compromised.

Leisure-Time Physical Activity and Health-Care Utilization in Older Adults

2006 ◽  
Vol 14 (4) ◽  
pp. 392-410 ◽  
Author(s):  
Michelle Y. Martin ◽  
M. Paige Powell ◽  
Claire Peel ◽  
Sha Zhu ◽  
Richard Allman
Keyword(s):  
Physical Activity ◽  
Older Adults ◽  
Health Care ◽  
Health Care Utilization ◽  
Leisure Time ◽  
Leisure Time Physical Activity ◽  
Community Dwelling ◽  
Care Utilization ◽  
Physically Active ◽  
Physician Visits

This study examined whether leisure-time physical activity (LTPA) was associated with health-care utilization in a racially diverse sample of rural and urban older adults. Community-dwelling adults (N= 1,000, 75.32 ± 6.72 years old) self-reported participating in LTPA and their use of the health-care system (physician visits, number and length of hospitalizations, and emergency-room visits). After controlling for variables associated with health and health-care utilization, older adults who reported lower levels of LTPA also reported a greater number of nights in the hospital in the preceding year. There was no support, however, for a relationship between LTPA and the other indicators of health-care utilization. Our findings suggest that being physically active might translate to a quicker recovery for older adults who are hospitalized. Being physically active might not only have health benefits for older persons but also lead to lower health-care costs.

scholarly journals Economic burden of vertigo: a systematic review

2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Eva Kovacs ◽  
Xiaoting Wang ◽  
Eva Grill
Keyword(s):  
Systematic Review ◽  
Health Care ◽  
Economic Evaluation ◽  
Health Care Utilization ◽  
Economic Burden ◽  
Population Based ◽  
Care Utilization ◽  
Vestibular Disease ◽  
Societal Burden ◽  
Vestibular Vertigo

Abstract Background Vertigo, a highly prevalent disease, imposes a rising burden on the health care system, exacerbated by the ageing of the population; and further, contributes to a wide span of indirect burden due to reduced capacity to work or need of assistance in activities of daily living. The aim of this review was to summarise the evidence on the economic burden of vertigo. Methods All original studies published between 2008 and 2018 about the economic evaluation of peripheral or central vestibular vertigo in developed countries were considered eligible, unrestricted to setting, health care provider, or study type. Results The electronic search in three databases identified 154 studies from which 16 qualified for inclusion. All studies presented partial economic evaluation referring to a variety of vestibular vertigo including unspecified vertigo. Nine studies presented monetised cost results and seven studies reported health care utilization. Direct costs derived mainly from repeated and not well-targeted consultations at all levels of health care, excessive use of diagnostic imaging, and/or of emergency care. Considerable societal burden was caused by decreased productivity, mainly due to work absenteeism. Conclusion To the best of our knowledge, this is the first systematic review of the existing evidence of the economic burden of vertigo. The lack of conclusive evidence revealed apparent targets of future research. First, studies of diagnostics and therapies for vestibular disease should include cost-effectiveness considerations. Population-based studies of health services utilization should include simple vestibular assessments to get more reliable estimates of the burden of disease and associated costs on the level of the general population. Further, clinical and population-based registries that include patients with vestibular disease, should consider collecting long-term data of societal burden. Primary data collection should increasingly include assessment of health care utilization e.g. by linking their diagnoses and outcomes to routine data from health insurances.

scholarly journals Effect of mood and anxiety disorders on health care utilization in multiple sclerosis

2020 ◽  
pp. 135245852096388
Author(s):  
Ruth Ann Marrie ◽  
Randy Walld ◽  
James M Bolton ◽  
Jitender Sareen ◽  
Scott B Patten ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Health Care ◽  
Anxiety Disorders ◽  
Health Care Utilization ◽  
Care Utilization ◽  
Health Services Use ◽  
Physician Visits ◽  
Mood And Anxiety Disorders ◽  
Drug Classes ◽  
Hospital Days

Background: Little is known about the effects of changes in the presence or absence of psychiatric disorders on health care utilization in multiple sclerosis (MS). Objective: To evaluate the association between “active” mood and anxiety disorders (MAD) and health care utilization in MS. Methods: Using administrative data from Manitoba, Canada, we identified 4748 persons with MS and 24,154 persons without MS matched on sex, birth year, and region. Using multivariable general linear models, we evaluated the within-person and between-person effects of any “active” MAD on annual physician visits, hospital days, and number of drug classes dispensed in the following year. Results: Annually, the MS cohort had an additional two physician visits, two drug classes, and nearly two more hospital days versus the matched cohort. Individuals with any MAD had more physician visits, had hospital days, and used more drug classes than individuals without a MAD. Within individuals, having an “active” MAD was associated with more utilization for all outcomes than not having an “active” MAD, but the magnitude of this effect was much smaller for visits and drugs than the between-person effect. Conclusion: Within individuals with MS, changes in MAD activity are associated with changes in health services use.

scholarly journals Health Care Utilization and Economic Burden of Pancreatic Cancer in The Us Medicare Population

2016 ◽  
Vol 19 (7) ◽  
pp. A726
Author(s):  
L Xie ◽  
Q Zhang ◽  
K Xin ◽  
Y Wang ◽  
H Yuce ◽  
...  
Keyword(s):  
Health Care ◽  
Pancreatic Cancer ◽  
Health Care Utilization ◽  
Economic Burden ◽  
Care Utilization ◽  
Medicare Population ◽  
The Us

scholarly journals The Effect of Back Pain on Health Care Utilization and Costs

2021 ◽  
Vol 2 (2) ◽  
Author(s):  
Jessica J Wong ◽  
Pierre Côté ◽  
Andrea C Tricco ◽  
Tristan Watson ◽  
Laura C Rosella
Keyword(s):  
Health Care ◽  
Back Pain ◽  
Propensity Score ◽  
Health Care Utilization ◽  
Canadian Community Health Survey ◽  
Population Based ◽  
Care Utilization ◽  
Physician Visits ◽  
Health Related ◽  
Behavioural Factors

Introduction: We assessed the effect of self-reported back pain on health care utilization and costs in a population-based sample of Ontario adults. Methods: We conducted a population-based matched cohort study of Ontarian respondents aged ≥18 years of Canadian Community Health Survey (CCHS) from 2003-2012. CCHS data were individually linked to health administrative data to measure health care utilization and costs up to 2018. We propensity-score matched (hard-matched on sex) adults with self-reported back pain to those without back pain, accounting for sociodemographic, health-related, and behavioural factors. We evaluated back pain-specific and all-cause health care utilization and costs from healthcare payer perspective adjusted to 2018 Canadian dollars. Poisson and linear (log-transformed) models were used to assess healthcare utilization rates and costs.  Results: After propensity-score matching, we identified 36,806 pairs (21,054 for women, 15,752 for men) of CCHS respondents with and without back pain (mean age 51 years; SD=18). Compared to propensity-score matched adults without back pain, adults with back pain had two times the rate of back pain-specific visits (women: rate ratio [RR] 2.06, 95% CI 1.88-2.25; men: RR 2.32, 95% CI 2.04-2.64), 1.1 times the rate of all-cause physician visits (women: RR 1.12, 95% CI 1.09-1.16; men: RR 1.10, 95% CI 1.05-1.14), and 1.2 times the costs (women: 1.21, 95% CI 1.16-1.27; men: 1.16, 95% CI 1.09-1.23). Incremental annual per-person costs were higher in adults with back pain versus those without (women: $395, 95% CI $281-$509; men: $196, 95% CI $94-$300), corresponding to $532 million for women and $227 million CAD for men annually in Ontario. Conclusions: Adults with back pain had considerably higher health care utilization and costs compared to adults without back pain. These findings provide the most recent, comprehensive, and high-quality estimates of the health system burden of back pain to inform healthcare policy and decision-making. New strategies to reduce the substantial burden of back pain are warranted.

scholarly journals Patterns of Collaboration among Health Care and Social Services Providers in Communities with Lower Health Care Utilization and Costs

2017 ◽  
Vol 53 ◽  
pp. 2892-2909 ◽  
Author(s):  
Amanda L. Brewster ◽  
Marie A. Brault ◽  
Annabel X. Tan ◽  
Leslie A. Curry ◽  
Elizabeth H. Bradley
Keyword(s):  
Health Care ◽  
Health Care Utilization ◽  
Social Services ◽  
Care Utilization ◽  
Lower Health

scholarly journals Evaluating The Economic Burden and Health Care Utilization of Lung Cancer in The Us Medicare Population

2016 ◽  
Vol 19 (7) ◽  
pp. A726
Author(s):  
L Xie ◽  
N Vaidya ◽  
K Xin ◽  
A Keshishian ◽  
H Yuce ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Health Care ◽  
Health Care Utilization ◽  
Economic Burden ◽  
Care Utilization ◽  
Medicare Population ◽  
The Us

scholarly journals The Impact of Psychiatric Comorbidity on Health Care Utilization in Inflammatory Bowel Disease: A Population-based Study

2020 ◽  
Author(s):  
Charles N Bernstein ◽  
Carol A Hitchon ◽  
Randy Walld ◽  
James M Bolton ◽  
Lisa M Lix ◽  
...  
Keyword(s):  
Health Care ◽  
Inflammatory Bowel Disease ◽  
Health Care Utilization ◽  
Bowel Disease ◽  
Psychiatric Comorbidity ◽  
Care Utilization ◽  
Physician Visits ◽  
Inflammatory Bowel ◽  
Hospital Days ◽  
The Impact

Abstract Background Inflammatory bowel disease (IBD) is associated with an increase in psychiatric comorbidity (PC) compared with the general population. We aimed to determine the impact of PC on health care utilization in persons with IBD. Methods We applied a validated administrative definition of IBD to identify all Manitobans with IBD from April 1, 2006, to March 31, 2016, and a matched cohort without IBD. A validated definition for PC in IBD population was applied to both cohorts; active PC status meant ≥2 visits for psychiatric diagnoses within a given year. We examined the association of active PC with physician visits, inpatient hospital days, proportion with inpatient hospitalization, and use of prescription IBD medications in the following year. We tested for the presence of a 2-way interaction between cohort and PC status. Results Our study matched 8459 persons with IBD to 40,375 controls. On crude analysis, IBD subjects had ≥3.7 additional physician visits, had &gt;1.5 extra hospital days, and used 2.1 more drug types annually than controls. Subjects with active PC had &gt;10 more physician visits, had 3.1 more hospital days, and used &gt;6.3 more drugs. There was a synergistic effect of IBD (vs no IBD) and PC (vs no PC) across psychiatric disorders of around 4%. This synergistic effect was greatest for anxiety (6% [2%, 9%]). After excluding psychiatry-related visits and psychiatry-related hospital stays, there remained an excess health care utilization in persons with IBD and PC. Conclusion Inflammatory bowel disease with PC increases health care utilization compared with matched controls and compared with persons with IBD without PC. Active PC further increases health care utilization.

Sign in / Sign up

Export Citation Format

Share Document